Cabaletta Bio, Inc. Stock Analysis & AI Score
Cabaletta Bio, Inc. (CABA) has an ST Score of 45.5 (C+), driven by its Sentiment (A+) and held back by its Momentum (D-). Analysts rate it Buy with a $16.33 price target (+657.8% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Cabaletta Bio, Inc. (CABA) has an ST Score of 45.5 (C+), driven by its Sentiment (A+) and held back by its Momentum (D-). Analysts rate it Buy with a $16.33 price target (+657.8% upside).
- Strongest
- SentimentA+
- Weakest
- MomentumD-
All factor grades
- SentimentA+
- ForecastA
- ValuationB
- GrowthC+
- Financial StrengthC-
- ProfitabilityD-
- MomentumD-
- Piotroski2/9
Contact
CABA stock: frequently asked questions
What is CABA's ST Score?
Cabaletta Bio, Inc. (CABA) has an ST Score of 45.5 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CABA a buy, hold, or sell?
Analysts rate CABA a Buy, with a price target of $16.33 (+657.8% vs the current price). Our ST Score grades it C+ (45.5/100). The ST Score is a data-driven signal, not a recommendation.
What are CABA's factor grades?
Valuation B, Profitability D-, Financial Strength C-, Momentum D-, Growth C+, Forecast A, Sentiment A+.
What is CABA's valuation grade?
Cabaletta Bio, Inc. (CABA) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CABA's growth grade?
Cabaletta Bio, Inc. (CABA) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CABA's profitability grade?
Cabaletta Bio, Inc. (CABA) earns a profitability grade of D-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CABA's financial strength grade?
Cabaletta Bio, Inc. (CABA) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for CABA?
The average analyst price target for Cabaletta Bio, Inc. (CABA) is $16.33 from 12 analysts, which is +657.8% versus the recent price of $2.15.
What is CABA's Piotroski score?
Cabaletta Bio, Inc. (CABA) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.